We are live on ! Find out more
LUXAW

Lux Health Tech Acquisition Corp. Warrants
LUXAW

Delisted

LUXAW was delisted on the 28th of October, 2022.

0 hedge funds and large institutions have $0 invested in Lux Health Tech Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 340 (-34)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $1.39M → $0 (-$1.39M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 33

Holders
Holders Change
-34
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
33
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PI
26
PEAK6 Investments
Illinois
-$3K -29,047 Closed
ISL
27
Ingalls & Snyder LLC
New York
-$3K -21,040 Closed
FTUS
28
Flow Traders U.S.
New York
-$1K -12,596 Closed
UBS Group
29
UBS Group
Switzerland
-$1K -8,558 Closed
Nomura Holdings
30
Nomura Holdings
Japan
-$1K -8,333 Closed
GCL
31
Glazer Capital LLC
New York
-$1K -6,012 Closed

LUXAW Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Warrants (LUXAW) for Q4 2022, worth a combined $0 — down 100% from $1.39M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of LUXAW and 0 opened new positions — a net loss of 33 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $668K sold.

  • 0 institutional investors held Lux Health Tech Acquisition Corp. Warrants (LUXAW) as of Q4 2022, down from 34 in Q3 2022.
  • Funds reported $0 of Lux Health Tech Acquisition Corp. Warrants stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Lux Health Tech Acquisition Corp. Warrants positions in Q4 2022 and 33 closed out, a net change of -33 holders.
  • The largest Lux Health Tech Acquisition Corp. Warrants seller in Q4 2022 was Radcliffe Capital Management, an estimated $668K sold.

Based on aggregated 13F filings for Q4 2022.